Global Pegfilgrastim Market Growth 2025-2031

December 2025 | 82 pages | ID: G78C376F0A0EN
LP Information

Abstracts

The global Pegfilgrastim market size is predicted to grow from US$ 60.7 million in 2025 to US$ 81.2 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).

Pegfilgrastim, also known by the brand name Neulasta, is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. The global market for pegfilgrastim is driven by several factors. One major driver for the global market is the increasing incidence and prevalence of cancer worldwide. As the number of cancer patients undergoing chemotherapy grows, the demand for medications like pegfilgrastim to manage chemotherapy-induced neutropenia (low white blood cell counts) increases. This has contributed to the market drive for pegfilgrastim. Additionally, the growing awareness and understanding of the impact of neutropenia on patient outcomes have led to the incorporation of supportive care strategies, including the use of pegfilgrastim, in cancer treatment protocols. Healthcare professionals are recognizing the importance of maintaining patients' immune systems during chemotherapy, leading to increased utilization of pegfilgrastim. Another factor driving the global market is the increasing adoption of biosimilar versions of pegfilgrastim. Biosimilars are biologic medications that are highly similar to a reference or originator biologic drug. The introduction of biosimilar pegfilgrastim options has created competition in the market, making the medication more accessible and affordable for patients and healthcare systems. Moreover, advancements in drug delivery systems have played a role in driving the market for pegfilgrastim. For instance, the development of on-body injectors that provide a longer duration of drug release has improved convenience and patient compliance. These innovations have contributed to the market drive for pegfilgrastim. Furthermore, government initiatives and policies aimed at reducing the healthcare burden of cancer treatment have also influenced the market drive for pegfilgrastim. Various healthcare systems and insurance providers have implemented measures to improve the affordability and accessibility of essential cancer treatments, including pegfilgrastim.

LP Information, Inc. (LPI) ' newest research report, the “Pegfilgrastim Industry Forecast” looks at past sales and reviews total world Pegfilgrastim sales in 2024, providing a comprehensive analysis by region and market sector of projected Pegfilgrastim sales for 2025 through 2031. With Pegfilgrastim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pegfilgrastim industry.

This Insight Report provides a comprehensive analysis of the global Pegfilgrastim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pegfilgrastim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pegfilgrastim market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pegfilgrastim and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pegfilgrastim.

This report presents a comprehensive overview, market shares, and growth opportunities of Pegfilgrastim market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Originator Biologic Drug
• Biosimilar Versions

Segmentation by Application:

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Amgen
• Mylan
• Roche

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pegfilgrastim market?

What factors are driving Pegfilgrastim market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pegfilgrastim market opportunities vary by end market size?

How does Pegfilgrastim break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pegfilgrastim Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pegfilgrastim by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pegfilgrastim by Country/Region, 2020, 2024 & 2031
2.2 Pegfilgrastim Segment by Type
  2.2.1 Originator Biologic Drug
  2.2.2 Biosimilar Versions
2.3 Pegfilgrastim Sales by Type
  2.3.1 Global Pegfilgrastim Sales Market Share by Type (2020-2025)
  2.3.2 Global Pegfilgrastim Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pegfilgrastim Sale Price by Type (2020-2025)
2.4 Pegfilgrastim Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Pegfilgrastim Sales by Application
  2.5.1 Global Pegfilgrastim Sale Market Share by Application (2020-2025)
  2.5.2 Global Pegfilgrastim Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Pegfilgrastim Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pegfilgrastim Breakdown Data by Company
  3.1.1 Global Pegfilgrastim Annual Sales by Company (2020-2025)
  3.1.2 Global Pegfilgrastim Sales Market Share by Company (2020-2025)
3.2 Global Pegfilgrastim Annual Revenue by Company (2020-2025)
  3.2.1 Global Pegfilgrastim Revenue by Company (2020-2025)
  3.2.2 Global Pegfilgrastim Revenue Market Share by Company (2020-2025)
3.3 Global Pegfilgrastim Sale Price by Company
3.4 Key Manufacturers Pegfilgrastim Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pegfilgrastim Product Location Distribution
  3.4.2 Players Pegfilgrastim Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PEGFILGRASTIM BY GEOGRAPHIC REGION

4.1 World Historic Pegfilgrastim Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pegfilgrastim Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pegfilgrastim Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pegfilgrastim Market Size by Country/Region (2020-2025)
  4.2.1 Global Pegfilgrastim Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pegfilgrastim Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pegfilgrastim Sales Growth
4.4 APAC Pegfilgrastim Sales Growth
4.5 Europe Pegfilgrastim Sales Growth
4.6 Middle East & Africa Pegfilgrastim Sales Growth

5 AMERICAS

5.1 Americas Pegfilgrastim Sales by Country
  5.1.1 Americas Pegfilgrastim Sales by Country (2020-2025)
  5.1.2 Americas Pegfilgrastim Revenue by Country (2020-2025)
5.2 Americas Pegfilgrastim Sales by Type (2020-2025)
5.3 Americas Pegfilgrastim Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pegfilgrastim Sales by Region
  6.1.1 APAC Pegfilgrastim Sales by Region (2020-2025)
  6.1.2 APAC Pegfilgrastim Revenue by Region (2020-2025)
6.2 APAC Pegfilgrastim Sales by Type (2020-2025)
6.3 APAC Pegfilgrastim Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pegfilgrastim by Country
  7.1.1 Europe Pegfilgrastim Sales by Country (2020-2025)
  7.1.2 Europe Pegfilgrastim Revenue by Country (2020-2025)
7.2 Europe Pegfilgrastim Sales by Type (2020-2025)
7.3 Europe Pegfilgrastim Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pegfilgrastim by Country
  8.1.1 Middle East & Africa Pegfilgrastim Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pegfilgrastim Revenue by Country (2020-2025)
8.2 Middle East & Africa Pegfilgrastim Sales by Type (2020-2025)
8.3 Middle East & Africa Pegfilgrastim Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pegfilgrastim
10.3 Manufacturing Process Analysis of Pegfilgrastim
10.4 Industry Chain Structure of Pegfilgrastim

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pegfilgrastim Distributors
11.3 Pegfilgrastim Customer

12 WORLD FORECAST REVIEW FOR PEGFILGRASTIM BY GEOGRAPHIC REGION

12.1 Global Pegfilgrastim Market Size Forecast by Region
  12.1.1 Global Pegfilgrastim Forecast by Region (2026-2031)
  12.1.2 Global Pegfilgrastim Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pegfilgrastim Forecast by Type (2026-2031)
12.7 Global Pegfilgrastim Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Amgen
  13.1.1 Amgen Company Information
  13.1.2 Amgen Pegfilgrastim Product Portfolios and Specifications
  13.1.3 Amgen Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Amgen Main Business Overview
  13.1.5 Amgen Latest Developments
13.2 Mylan
  13.2.1 Mylan Company Information
  13.2.2 Mylan Pegfilgrastim Product Portfolios and Specifications
  13.2.3 Mylan Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Mylan Main Business Overview
  13.2.5 Mylan Latest Developments
13.3 Roche
  13.3.1 Roche Company Information
  13.3.2 Roche Pegfilgrastim Product Portfolios and Specifications
  13.3.3 Roche Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Roche Main Business Overview
  13.3.5 Roche Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pegfilgrastim Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pegfilgrastim Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Originator Biologic Drug
Table 4. Major Players of Biosimilar Versions
Table 5. Global Pegfilgrastim Sales by Type (2020-2025) & (K Units)
Table 6. Global Pegfilgrastim Sales Market Share by Type (2020-2025)
Table 7. Global Pegfilgrastim Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pegfilgrastim Revenue Market Share by Type (2020-2025)
Table 9. Global Pegfilgrastim Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pegfilgrastim Sale by Application (2020-2025) & (K Units)
Table 11. Global Pegfilgrastim Sale Market Share by Application (2020-2025)
Table 12. Global Pegfilgrastim Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pegfilgrastim Revenue Market Share by Application (2020-2025)
Table 14. Global Pegfilgrastim Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pegfilgrastim Sales by Company (2020-2025) & (K Units)
Table 16. Global Pegfilgrastim Sales Market Share by Company (2020-2025)
Table 17. Global Pegfilgrastim Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pegfilgrastim Revenue Market Share by Company (2020-2025)
Table 19. Global Pegfilgrastim Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pegfilgrastim Producing Area Distribution and Sales Area
Table 21. Players Pegfilgrastim Products Offered
Table 22. Pegfilgrastim Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pegfilgrastim Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pegfilgrastim Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pegfilgrastim Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pegfilgrastim Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pegfilgrastim Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pegfilgrastim Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pegfilgrastim Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pegfilgrastim Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pegfilgrastim Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pegfilgrastim Sales Market Share by Country (2020-2025)
Table 35. Americas Pegfilgrastim Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pegfilgrastim Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pegfilgrastim Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pegfilgrastim Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pegfilgrastim Sales Market Share by Region (2020-2025)
Table 40. APAC Pegfilgrastim Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pegfilgrastim Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pegfilgrastim Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pegfilgrastim Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pegfilgrastim Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pegfilgrastim Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pegfilgrastim Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pegfilgrastim Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pegfilgrastim Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pegfilgrastim Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pegfilgrastim Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pegfilgrastim
Table 52. Key Market Challenges & Risks of Pegfilgrastim
Table 53. Key Industry Trends of Pegfilgrastim
Table 54. Pegfilgrastim Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pegfilgrastim Distributors List
Table 57. Pegfilgrastim Customer List
Table 58. Global Pegfilgrastim Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pegfilgrastim Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pegfilgrastim Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pegfilgrastim Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pegfilgrastim Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pegfilgrastim Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pegfilgrastim Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pegfilgrastim Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pegfilgrastim Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pegfilgrastim Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pegfilgrastim Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pegfilgrastim Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pegfilgrastim Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pegfilgrastim Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Amgen Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Pegfilgrastim Product Portfolios and Specifications
Table 74. Amgen Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. Mylan Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 78. Mylan Pegfilgrastim Product Portfolios and Specifications
Table 79. Mylan Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Mylan Main Business
Table 81. Mylan Latest Developments
Table 82. Roche Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche Pegfilgrastim Product Portfolios and Specifications
Table 84. Roche Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Roche Main Business
Table 86. Roche Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pegfilgrastim
Figure 2. Pegfilgrastim Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pegfilgrastim Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pegfilgrastim Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pegfilgrastim Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pegfilgrastim Sales Market Share by Country/Region (2024)
Figure 10. Pegfilgrastim Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Originator Biologic Drug
Figure 12. Product Picture of Biosimilar Versions
Figure 13. Global Pegfilgrastim Sales Market Share by Type in 2025
Figure 14. Global Pegfilgrastim Revenue Market Share by Type (2020-2025)
Figure 15. Pegfilgrastim Consumed in Hospital
Figure 16. Global Pegfilgrastim Market: Hospital (2020-2025) & (K Units)
Figure 17. Pegfilgrastim Consumed in Drug store
Figure 18. Global Pegfilgrastim Market: Drug store (2020-2025) & (K Units)
Figure 19. Global Pegfilgrastim Sale Market Share by Application (2024)
Figure 20. Global Pegfilgrastim Revenue Market Share by Application in 2025
Figure 21. Pegfilgrastim Sales by Company in 2025 (K Units)
Figure 22. Global Pegfilgrastim Sales Market Share by Company in 2025
Figure 23. Pegfilgrastim Revenue by Company in 2025 ($ millions)
Figure 24. Global Pegfilgrastim Revenue Market Share by Company in 2025
Figure 25. Global Pegfilgrastim Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Pegfilgrastim Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Pegfilgrastim Sales 2020-2025 (K Units)
Figure 28. Americas Pegfilgrastim Revenue 2020-2025 ($ millions)
Figure 29. APAC Pegfilgrastim Sales 2020-2025 (K Units)
Figure 30. APAC Pegfilgrastim Revenue 2020-2025 ($ millions)
Figure 31. Europe Pegfilgrastim Sales 2020-2025 (K Units)
Figure 32. Europe Pegfilgrastim Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Pegfilgrastim Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Pegfilgrastim Revenue 2020-2025 ($ millions)
Figure 35. Americas Pegfilgrastim Sales Market Share by Country in 2025
Figure 36. Americas Pegfilgrastim Revenue Market Share by Country (2020-2025)
Figure 37. Americas Pegfilgrastim Sales Market Share by Type (2020-2025)
Figure 38. Americas Pegfilgrastim Sales Market Share by Application (2020-2025)
Figure 39. United States Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Pegfilgrastim Sales Market Share by Region in 2025
Figure 44. APAC Pegfilgrastim Revenue Market Share by Region (2020-2025)
Figure 45. APAC Pegfilgrastim Sales Market Share by Type (2020-2025)
Figure 46. APAC Pegfilgrastim Sales Market Share by Application (2020-2025)
Figure 47. China Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 51. India Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Pegfilgrastim Sales Market Share by Country in 2025
Figure 55. Europe Pegfilgrastim Revenue Market Share by Country (2020-2025)
Figure 56. Europe Pegfilgrastim Sales Market Share by Type (2020-2025)
Figure 57. Europe Pegfilgrastim Sales Market Share by Application (2020-2025)
Figure 58. Germany Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 59. France Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Pegfilgrastim Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Pegfilgrastim Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Pegfilgrastim Sales Market Share by Application (2020-2025)
Figure 66. Egypt Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Pegfilgrastim Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pegfilgrastim in 2025
Figure 72. Manufacturing Process Analysis of Pegfilgrastim
Figure 73. Industry Chain Structure of Pegfilgrastim
Figure 74. Channels of Distribution
Figure 75. Global Pegfilgrastim Sales Market Forecast by Region (2026-2031)
Figure 76. Global Pegfilgrastim Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Pegfilgrastim Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Pegfilgrastim Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Pegfilgrastim Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Pegfilgrastim Revenue Market Share Forecast by Application (2026-2031)